288 related articles for article (PubMed ID: 20960509)
1. Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.
Kramer MW; Escudero DO; Lokeshwar SD; Golshani R; Ekwenna OO; Acosta K; Merseburger AS; Soloway M; Lokeshwar VB
Cancer; 2011 Mar; 117(6):1197-209. PubMed ID: 20960509
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis.
Chi A; Shirodkar SP; Escudero DO; Ekwenna OO; Yates TJ; Ayyathurai R; Garcia-Roig M; Gahan JC; Manoharan M; Bird VG; Lokeshwar VB
Cancer; 2012 May; 118(9):2394-402. PubMed ID: 21887686
[TBL] [Abstract][Full Text] [Related]
3. HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
Kramer MW; Golshani R; Merseburger AS; Knapp J; Garcia A; Hennenlotter J; Duncan RC; Soloway MS; Jorda M; Kuczyk MA; Stenzl A; Lokeshwar VB
Eur Urol; 2010 Jan; 57(1):86-93. PubMed ID: 19345473
[TBL] [Abstract][Full Text] [Related]
4. HAS1 expression in bladder cancer and its relation to urinary HA test.
Golshani R; Hautmann SH; Estrella V; Cohen BL; Kyle CC; Manoharan M; Jorda M; Soloway MS; Lokeshwar VB
Int J Cancer; 2007 Apr; 120(8):1712-20. PubMed ID: 17230515
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.
Paiva P; Van Damme MP; Tellbach M; Jones RL; Jobling T; Salamonsen LA
Gynecol Oncol; 2005 Aug; 98(2):193-202. PubMed ID: 15936804
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
[TBL] [Abstract][Full Text] [Related]
7. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.
Nykopp TK; Rilla K; Sironen R; Tammi MI; Tammi RH; Hämäläinen K; Heikkinen AM; Komulainen M; Kosma VM; Anttila M
BMC Cancer; 2009 May; 9():143. PubMed ID: 19435493
[TBL] [Abstract][Full Text] [Related]
8. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
Udabage L; Brownlee GR; Nilsson SK; Brown TJ
Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
[TBL] [Abstract][Full Text] [Related]
9. Dose- and time-dependent effects of hyaluronidase on structural cells and the extracellular matrix of the skin.
Buhren BA; Schrumpf H; Gorges K; Reiners O; Bölke E; Fischer JW; Homey B; Gerber PA
Eur J Med Res; 2020 Nov; 25(1):60. PubMed ID: 33228813
[TBL] [Abstract][Full Text] [Related]
10. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
11. [Differential expression of hyaluronic acid synthase family in human bladder transitional cell carcinoma and its clinical significance].
Cai JL; Li M; Na YQ
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):121-5. PubMed ID: 21575480
[TBL] [Abstract][Full Text] [Related]
12. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.
Jordan AR; Lokeshwar SD; Lopez LE; Hennig M; Chipollini J; Yates T; Hupe MC; Merseburger AS; Shiedlin A; Cerwinka WH; Liu K; Lokeshwar VB
Oncotarget; 2017 Apr; 8(15):24262-24274. PubMed ID: 27419371
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
[TBL] [Abstract][Full Text] [Related]
15. Myofibroblastic differentiation leads to hyaluronan accumulation through reduced hyaluronan turnover.
Jenkins RH; Thomas GJ; Williams JD; Steadman R
J Biol Chem; 2004 Oct; 279(40):41453-60. PubMed ID: 15271981
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure.
Weiss I; Trope CG; Reich R; Davidson B
Int J Mol Sci; 2012 Oct; 13(10):12925-38. PubMed ID: 23202930
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid, HAS1, and HAS2 are significantly upregulated during muscle hypertrophy.
Calve S; Isaac J; Gumucio JP; Mendias CL
Am J Physiol Cell Physiol; 2012 Sep; 303(5):C577-88. PubMed ID: 22785117
[TBL] [Abstract][Full Text] [Related]
18. Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.
Hautmann SH; Lokeshwar VB; Schroeder GL; Civantos F; Duncan RC; Gnann R; Friedrich MG; Soloway MS
J Urol; 2001 Jun; 165(6 Pt 1):2068-74. PubMed ID: 11371930
[TBL] [Abstract][Full Text] [Related]
19. The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer.
Riecks J; Parnigoni A; Győrffy B; Kiesel L; Passi A; Vigetti D; Götte M
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3399-3419. PubMed ID: 35767191
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus.
Siponen M; Kullaa A; Nieminen P; Salo T; Pasonen-Seppänen S
J Oral Pathol Med; 2015 Jul; 44(6):401-9. PubMed ID: 25421996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
